|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Enanta Pharmaceuticals (NASDAQ: ENTA) through any online brokerage.
The latest price target for Enanta Pharmaceuticals (NASDAQ: ENTA) was reported by Oppenheimer on November 24, 2021. The analyst firm set a price target for 73.00 expecting ENTA to fall to within 12 months (a possible -16.64% downside). 15 analyst firms have reported ratings in the last year.
The stock price for Enanta Pharmaceuticals (NASDAQ: ENTA) is $87.57 last updated Mon Nov 29 2021 21:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Enanta Pharmaceuticals.
Enanta Pharmaceuticals’s $Q1 earnings are confirmed for after-market on February 7, 2022.
There is no upcoming split for Enanta Pharmaceuticals.
Enanta Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.